A field study comparing two vaccine regimes against pancreas disease (PD) was carried out in 2018 S0 year class smolts at two commercial sea cage sites in southern Norway. The fish from the same hatchery source were immunized using licensed vaccines; either a DNA PD vaccine and a hexavalent oil‐adjuvanted vaccine (group A), or a heptavalent oil‐adjuvanted PD vaccine (group B). The experimental design included the two fish groups reared together (15% as group A and 85% as group B) in four large hatchery tanks. These fish groups were later transferred to four production cages at two separate sea sites (two cages per site). In the absence of any notable PD prior to the pre‐harvest sampling, the primary objective and outcome variables entailed evaluation of vaccine side effects and their impact on growth. The results show that vaccine and sea cage site significantly impacted prevalence and severity of a newly described pathology named cross‐stitch vertebrae. Further, moderate to severe cross‐stitch pathology (scores ≥3) resulted in significantly reduced growth.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.